We are live on ! Find out more
AEMD icon

Aethlon Medical

14 hedge funds and large institutions have $389K invested in Aethlon Medical in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

17% more funds holding

Funds holding: 1214 (+2)

4.54% more ownership

Funds ownership: 15.51%20.05% (+4.5%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

19% less capital invested

Capital invested by funds: $481K → $389K (-$92K)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
1
Reduced
1
Closed
6
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q3 2025 in Review

14 of the 7,643 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2025, worth a combined $389K — down 19% from $481K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AEMD positions and 6 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $151K. The largest seller was Armistice Capital, exiting entirely with an estimated $222K sold.

  • 14 institutional investors held Aethlon Medical (AEMD) as of Q3 2025, up from 12 in Q2 2025.
  • Funds reported $389K of Aethlon Medical stock for Q3 2025, down 19% quarter-over-quarter.
  • 8 funds opened new Aethlon Medical positions in Q3 2025 and 6 closed out, a net change of +2 holders.
  • The largest Aethlon Medical buyer in Q3 2025 was HRT Financial, an estimated $151K added.
  • The largest Aethlon Medical seller in Q3 2025 was Armistice Capital, an estimated $222K sold.

Based on aggregated 13F filings for Q3 2025.